Salute e Benessere | Diffusione Gratuita di Comunicati Stampa in inglese| Pubblica i tuoi comunicati con informazione.news

CXCR Inhibitors Market Set to Gain Momentum with Emerging Clinical Successes and…

Key Takeaways from the CXCR Inhibitors Market Report Key Takeaways from the CXCR Inhibitors Market Report Discover which indication is expected to grab the major CXCR inhibitors market share @CXCR Inhibitors Market Report Key Factors Driving the CXCR Inhibitors Market Rising Oncology and Hematologic Disease Burden The growing incidence of cancers and hematologic malignancies increases demand for targeted therapies that address metastasis, chemo-resistance, and stem-cell...

Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share…

The tender offer period will expire at one minute after 11:59 p.m., New York City time on October 29, 2025, unless the offer is extended.Roche has filed a tender offer statement on Schedule TO with the United States Securities and Exchange Commission (SEC). Bluefin Merger Subsidiary, Inc. is the acquirer in the tender offer. The Offer to Purchase contained within the Schedule TO sets out the terms and conditions of the tender offer.89bio has also filed a Solicitation/Recommendation...

NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3)…

Treatment was well-tolerated and injection feasibility was confirmed in 13 patients with locally advanced adenocarcinoma of the esophagus85% (11/13) disease control rate (DCR)69% (9/13) objective response rate (ORR); 6 complete responses and 3 partial responsesRecruitment of 17 additional patients is ongoing as plannedData presented at the 2025 Annual Meeting of the American Society for Radiation Oncology (ASTRO) on October 1 stPARIS and CAMBRIDGE, Mass., Oct.01, 2025...

Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy…

Mechelen, Belgium; October 1, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and its Board of Directors today issued the following statement: On May 13, 2025, Galapagos announced that its Board of Directors (the “Board”) had decided to explore all strategic alternatives for its cell therapy business (the “Cell Therapy Business”), including a potential divestiture of the Cell Therapy Business, with the goal of preserving shareholder value.As part of its review of strategic...

EssilorLuxottica completes acquisition of Optegra

EssilorLuxottica completes acquisition of OptegraParis, France (1 October 2025)– EssilorLuxottica announces that it has successfully completed theacquisition of Optegrafrom MidEuropa. Under the Optegra, Lexum and Iris brands, Optegra is a fast-growing and highly integrated ophthalmology platform operating an extensive network of over 70 eye hospitals and diagnostic facilities in five key European markets: the UK, Czech Republic, Poland, Slovakia and the Netherlands.A natural fit...

Weight Loss Supplement Market Size to Reach US$ 108 Billion by 2033, Growing at…

Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/weight-loss-supplement-market Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/weight-loss-supplement-market Browse in-depth TOC on 'Weight Loss Supplement Market' 61 – Tables 65 – Figures 180 – Pages The fat burners segment is...

Kidney Transplant Market Size to Reach US$ 42.8 Bn by 2033, Driven by…

Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/kidney-transplant-market Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/kidney-transplant-market Rising Cadaveric Allografts, Living Donors & Immunosuppressants Drive Transplant Market Growth Allografts from deceased donors make up most...

Endodontics Market worth $ 2.49 billion by 2030 with 5.2% CAGR |…

Browse in-depth TOC on "Endodontics Market" Browse in-depth TOC on "Endodontics Market" 285 - Tables54- Figures296 - Pages By product type,the global endodontics market is divided into two main segments: access preparation equipment & consumables, and procedural instruments. The access preparation equipment & consumables segment is anticipated to register the highest CAGR, led by a rise in the adoption of single-use endodontic products and enhanced awareness...

Bioresorbable Implants Market to Double, Hitting US$ 14.34 Billion by 2033 as…

Download Exclusive Sample Report: https://www.datamintelligence.com/download-sample/bioresorbable-implants-market Download Exclusive Sample Report:https://www.datamintelligence.com/download-sample/bioresorbable-implants-market Browse in-depth TOC on "Bioresorbable Implants Market" 45 – Tables 46 – Figures 180 – Pages Market Segmentation – Growth Anchors By Material Type In 2024,polymer-based implants dominated with 60% of total revenues ( US$ 4.2 billion )...

Human Appeal Launches Birmingham’s First ‘Third Space’ Community Hub in…

The initiative – the first of its kind in Birmingham – is designed to be a‘ home away from home ’for local residents, offering a welcoming space where people can come together to belong, connect, and uplift one another. ‘ The Third Space’ aims to provide more than just a gathering place. It will serve as a vibrant centre of community life with opportunities for educational classes, social gatherings, volunteering, spiritual connection, and essential community services.The launch...

Next Level Aviation® Appoints Danny Budding as Senior Vice President of Sales -…

Next Level Aviation® EVP-Sales & Procurement Mike Dreyer commented, "We are very excited to have Danny join the team. His leadership, pedigree, and product knowledge are a huge addition to Next Level Aviation." Next Level Aviation ®EVP-Sales & Procurement Mike Dreyer commented, "We are very excited to have Danny join the team. His leadership, pedigree, and product knowledge are a huge addition to Next Level Aviation." SVP of Sales-Global Danny Budding stated…

Bioretec's RemeOs™ Screw LAG Solid Receives CMS Transitional Pass-Through…

The approval is reflected in the October 2025 Healthcare Common Procedure Coding System (HCPCS) quarterly update, which establishes a new billing code, C1741, for absorbable anchor/screw implants. This designation makes RemeOs™ eligible for separate pass-through payment under both the Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) payment system, providing incremental reimbursement for Medicare patients. The approval is reflected in theOctober 2025...

Kolmar Korea Presents "K-Beauty Success Roadmap" in Amazon Beauty in Seoul

During the "Global Vision" session, Vice Chairman Yoon delivered a keynote address titled "K-Beauty Success from a Manufacturer's Perspective." He stated, "Without evolution, companies cannot avoid being left behind. Relentless effort and constant innovation are essential to building a successful brand." Yoon went on to explain, "Korean consumers are among the most demanding in the world, and it is this intensely competitive domestic market experience that has…

CMEF 2025: Innovation Drives Global Synergy in Healthcare Ecosystem

Exhibition Highlights Exhibition Highlights Medical Imaging Zone: The "Imaging Pulse • Smart Link" solution, including domestically produced digital cardiac-specific SPECT and large flat-panel mobile C-arm, attracted strong attention. Medical Robotics Zone: Advanced orthopedic surgical robots—"Smart Brain," "Smart Eye," and "Smart Hand"—and a navigation system for total knee arthroplasty became focal points. Rehabilitation & Personal Health Zone…

Comphya Announces First Patient Implanted with CaverSTIM in U.S. Pilot Study at…

Pilot study evaluates safety and tolerability of implantable neuromodulation therapy for erectile dysfunction following radical prostatectomy TMlong-term use, with early insights into patient satisfaction and effectiveness.The single-site study, titled“Safety and tolerability of a novel implantable neurostimulator for the treatment of erectile dysfunction following radical prostatectomy,”is led by Arthur Burnett, MD, MBA, and Christian Pavlovich, MD, both distinguished professors of...

e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS

Relaunch marks pivotal next step in the company’s growth, in anticipation of first CTA submission in Q4 2025.Introducing LLibra OS, a next-generation AI platform that accelerates discovery and evaluation of differentiated gene targets and siRNA design. LONDON, Oct.01, 2025(GLOBE NEWSWIRE) -- Tangram Therapeutics (formerly e-therapeutics), a company committed to uniting computation and RNAi to make better medicines faster, today announced its corporate relaunch. Tangram Therapeutics...

Accumulus Synergy Appoints Khushboo Sharma as Chief Executive Officer

“On behalf of the Board, I am delighted to welcome Khushboo Sharma as the new CEO of Accumulus Synergy,” said Mark Taisey, Chairman of the Board. “Having worked with her over the last several years, I know that her leadership, expertise, and commitment to advancing regulatory progress make her uniquely positioned to guide the association forward. We are also grateful to Francisco for his leadership and vision in bringing us to this next phase.”During her tenure as Chief Regulatory...

HemostOD secures CHF 4.3 million seed extension to advance through pre-IND…

Lausanne, Switzerland — 1st October 2025– HemostOD, a private Swiss company pioneering theex vivomanufacturing of donor-free, off-the-shelf universal human blood platelets, today announced the successful closing of a CHF 4.3 million Seed-extension financing. The round was co-led by Polytech Ventures and Orenok Holdings, with additional participation from the Lichtsteiner Foundation and other private investors.Proceeds from this financing will support HemostOD’s pre-IND development,...

Immatics Appoints Venkat Ramanan as Chief Financial Officer

Houston , Texas and Tuebingen, Germany, October 1, 2025–Immatics N.V.(NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, today announced the appointment of Venkat Ramanan, Ph.D., as Chief Financial Officer (“CFO”), effective immediately. Dr. Ramanan is a seasoned financial leader in the biopharmaceutical industry with over 25 years of experience at companies including Seagen, Gilead Sciences and...

Pharmaceutical Packaging Market worth $364.11 billion by 2030 - Exclusive Report…

150 - Tables 70 - Figures300 - Pages 150 - Tables 70 - Figures 300 - Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=890 The pharmaceutical packaging market across primary and secondary applications has experienced substantial growth, primarily because safety, efficacy, and compliance requirements are becoming increasingly stringent across oral, injectable, and topical drug delivery formats. The growing global demand for...

AorticLab Receives FDA Approval to Initiate FLOWer™ Clinical Pivotal…

Medtecs Showcases Global Capabilities at MEDICA and A+A in Germany

Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System…

Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali…

CXCR Inhibitors Market Set to Gain Momentum with Emerging Clinical Successes and…

Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share…

NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3)…

Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy…

EssilorLuxottica completes acquisition of Optegra

Weight Loss Supplement Market Size to Reach US$ 108 Billion by 2033, Growing at…

Kidney Transplant Market Size to Reach US$ 42.8 Bn by 2033, Driven by…

Endodontics Market worth $ 2.49 billion by 2030 with 5.2% CAGR |…

Bioresorbable Implants Market to Double, Hitting US$ 14.34 Billion by 2033 as…

Human Appeal Launches Birmingham’s First ‘Third Space’ Community Hub in…

Next Level Aviation® Appoints Danny Budding as Senior Vice President of Sales -…

Bioretec's RemeOs™ Screw LAG Solid Receives CMS Transitional Pass-Through…

Kolmar Korea Presents "K-Beauty Success Roadmap" in Amazon Beauty in Seoul

CMEF 2025: Innovation Drives Global Synergy in Healthcare Ecosystem

Comphya Announces First Patient Implanted with CaverSTIM in U.S. Pilot Study at…

e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS

Accumulus Synergy Appoints Khushboo Sharma as Chief Executive Officer

HemostOD secures CHF 4.3 million seed extension to advance through pre-IND…

Immatics Appoints Venkat Ramanan as Chief Financial Officer

Pharmaceutical Packaging Market worth $364.11 billion by 2030 - Exclusive Report…